GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OSTO:RAY B) » Definitions » Total Assets

RaySearch Laboratories AB (OSTO:RAY B) Total Assets : kr2,064 Mil (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is RaySearch Laboratories AB Total Assets?

RaySearch Laboratories AB's Total Assets for the quarter that ended in Mar. 2024 was kr2,064 Mil.

Warning Sign:

If a company builds assets at 12.1% a year, faster than its revenue growth rate of 8.4% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, RaySearch Laboratories AB's average Total Assets Growth Rate was -1.10% per year. During the past 3 years, the average Total Assets Growth Rate was 13.00% per year. During the past 5 years, the average Total Assets Growth Rate was 12.10% per year. During the past 10 years, the average Total Assets Growth Rate was 21.30% per year.

During the past 13 years, RaySearch Laboratories AB's highest 3-Year average Total Assets Growth Rate was 60.40%. The lowest was 11.20%. And the median was 23.40%.

Total Assets is connected with ROA %. RaySearch Laboratories AB's annualized ROA % for the quarter that ended in Mar. 2024 was 7.31%. Total Assets is also linked to Revenue through Asset Turnover. RaySearch Laboratories AB's Asset Turnover for the quarter that ended in Mar. 2024 was 0.13.


RaySearch Laboratories AB Total Assets Historical Data

The historical data trend for RaySearch Laboratories AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB Total Assets Chart

RaySearch Laboratories AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,264.22 1,284.90 1,744.75 1,875.95 1,952.67

RaySearch Laboratories AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,885.31 1,897.77 1,866.60 1,952.67 2,064.20

RaySearch Laboratories AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

RaySearch Laboratories AB's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=735.232+1217.434
=1,953

RaySearch Laboratories AB's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=776.546+1287.656
=2,064

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RaySearch Laboratories AB  (OSTO:RAY B) Total Assets Explanation

Total Assets is connected with ROA %.

RaySearch Laboratories AB's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=146.792/( (1952.666+2064.202)/ 2 )
=146.792/2008.434
=7.31 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

RaySearch Laboratories AB's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=257.196/( (1952.666+2064.202)/ 2 )
=257.196/2008.434
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

RaySearch Laboratories AB Total Assets Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


RaySearch Laboratories AB (OSTO:RAY B) Business Description

Traded in Other Exchanges
Address
Sveavagen 44, P.O. Box 3297, Stockholm, SWE, 103 65
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.

RaySearch Laboratories AB (OSTO:RAY B) Headlines

No Headlines